Individualized Dosing of Therapeutic Monoclonal Antibodies:

A Changing Treatment 

Paradigm?

Identification of Peptide Mimotope Ligands for Natalizumab

A Phase I Study of Escalated dose subcutaneous Alemtuzumab given weekly with Rituximab in Relapsed chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma

A General Process for the Development of Peptide-based Immunoassays for Monoclonal Antibodies